112P Pseudoprogression predicts better prognosis in advanced non-small cell lung cancer treated with immune checkpoint inhibitors


Senturk Oztas N., Alkan G., Degerli E., Turna Z. H., Ozguroglu M.

Immuno-Oncology and Technology, vol.16, pp.1, 2022 (Conference Book)